Literature DB >> 2873833

Structure and properties of the cellular receptor for transforming growth factor type beta.

B O Fanger, L M Wakefield, M B Sporn.   

Abstract

Swiss 3T3 cells respond to picomolar concentrations of type beta transforming growth factor (TGF-beta) with a dose-dependent increase in the formation of colonies in soft agar, a decrease in the growth of cells in monolayer culture, and changes in morphology. This indicates that these cells have functional TGF-beta receptors able to mediate a biological response. Binding analysis revealed a single class of TGF-beta binding sites (80 000 per cell) with a Kd approximately 50 pM. Receptors were affinity-labeled by covalent attachment to 125I-TGF-beta with bis(sulfosuccinimidyl) suberate (BS3). The complexes formed were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis in the presence of 100 mM dithiothreitol and migrated as Mr approximately 180 000 complexes in 3-10% linear gradient gels. The apparent size of these complexes was larger in gels with a higher percentage of acrylamide. The labeling of the 125I-TGF-beta-receptor complexes was inhibited by the presence of excess unlabeled TGF-beta but was unaffected by other growth factors. These complexes could be formed by cross-linking whole cells, intact membranes, or solubilized membranes, demonstrating that the TGF-beta receptor is located on the plasma membrane and can be solubilized without destruction of its ability to bind TGF-beta. A larger Mr approximately 360 000 complex was present in 3-10% linear gradient gels without reduction or after extensive cross-linking, suggesting that the receptor consists of two subunits of similar size attached by disulfide bonds. Since BS3 is membrane-impermeable, at least a portion of both subunits is located on the outer surface of the plasma membrane.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873833     DOI: 10.1021/bi00359a003

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Parathyroid hormone modulates transforming growth factor beta activity and binding in osteoblast-enriched cell cultures from fetal rat parietal bone.

Authors:  M Centrella; T L McCarthy; E Canalis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

2.  Inhibitory action of transforming growth factor beta on endothelial cells.

Authors:  G Müller; J Behrens; U Nussbaumer; P Böhlen; W Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Effect of transforming growth factor beta (TGF-beta) on ATP citrate lyase in isolated hepatocytes.

Authors:  G Reinhart; K Roehrig
Journal:  Mol Cell Biochem       Date:  1987-10       Impact factor: 3.396

4.  Insulin-like synergistic stimulation of DNA synthesis in Swiss 3T3 cells by the BSC-1 cell-derived growth inhibitor related to transforming growth factor type beta.

Authors:  K D Brown; R W Holley
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

5.  Transforming growth factor-β receptors.

Authors:  P R Segarini
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

6.  The effects of type beta transforming growth factor on proliferation and epidermal growth factor receptor expression in a human glioblastoma cell line.

Authors:  E Helseth; G Unsgaard; A Dalen; R Vik
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

7.  Effects of type beta transforming growth factor in combination with retinoic acid or tumor necrosis factor on proliferation of a human glioblastoma cell line and clonogenic cells from freshly resected human brain tumors.

Authors:  E Helseth; G Unsgaard; A Dalen; R Vik
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

8.  Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions.

Authors:  S Nikol; J M Isner; J G Pickering; M Kearney; G Leclerc; L Weir
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

9.  Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA.

Authors:  M Inagaki; A Moustakas; H Y Lin; H F Lodish; B I Carr
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

Review 10.  Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.

Authors:  S M Wahl
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.